Skip to main content
OpenTrials
Completed

NCT Number: NCT06508905

Sleep Buddy Application in Hospitalized Children

The study was planned as a randomized controlled experimental study to investigate the effect of sleep companion application on psychosocial symptoms in hospitalized school children aged 6-12 years.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Main Heading (Descriptor) Terms

Age range

6 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medipol University

Istanbul, Beykoz, 34810, Turkey (Türkiye)

About this study

The sample of the study consisted of a total of 97 school-age children hospitalized in the Pediatrics and Pediatric Surgery-Endocrine Service of the Health Services Application and Research Hospital of a university hospital and in the Pediatrics Service of a state hospital. Children who met the inclusion criteria and whose written and verbal consent was obtained from their parents for participation in the study after being informed were included in the study.

The study was completed as 50 control and 47 experimental group with 3 missing persons in the experimental group.

Data were collected using the "Introductory Information Form" and "Psychosocial Symptoms Diagnostic Scale for Hospitalized Children (PSDS)" tools.

The toy, which was selected as a sleep companion for the children in the experimental group, was introduced to the children and accompanied them for 3 days during their hospitalization. The experimental and control groups were observed for psychosocial symptoms.

The data will be analyzed with SPSS software.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hospitalized school-age children (6-12 years old),
  • No mental disability,
  • Volunteer to participate in the research,
  • No allergies,
  • Children who are hospitalized for at least 3 days

Exclusion criteria

  • Hospitalized children under 6 years of age and over 12 years of age,
  • Predicted discharge in less than 3 days,
  • Children with a sleeping companion

Treatment and study plan

Sleep buddy

Other

The toy chosen as a sleep companion was introduced to the children in the experimental group and they were told that it would accompany them for 3 days during their hospitalization. Before giving the sleep companion, parents and children were informed about the sleep companion and their questions about the study were answered. Children who did not have their own sleep companion were included in the sample. The child was encouraged to sleep and spend time with the given sleep buddy and the family was also informed.

Primary outcomes

  1. Psychosocial symptoms diagnostic scale

    Time frame: Used 3 days after the sleep companion app. The scale administration took 15 minutes.

    Determination of psychosocial symptoms of hospitalized children The highest score that can be obtained from the scale is "48" and the lowest score is "0". A high score on the scale means that the hospitalized school child has psychosocial problems.

Sponsors and collaborators

Lead sponsor

Istanbul Medipol University Hospital

Other

Registry information

Official study title

The Effect of Sleep Companion Application on Psychosocial Symptoms in Hospitalized Children

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jul 18, 2024
Registry last updated
Apr 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.